International Codes
IFPMA Comparative Code Analyses 
(part 1) (part2)
The IFPMA Comparative Code Analyses provided here are taken from the IFPMA website. They may be seen as a useful adjunct to the other codes information provided in the IPCAA Regulatory Tool.
This Global Comparison of Research-based Pharmaceutical Codes of Marketing Practices Chart (Part 1 & Part 2) is the collected feedback from IFPMA member associations and provides a general overview of national and regional associations’ Codes and the associated provisions.
The Comparison Chart serves as a useful tool that provides a snapshot of the global research-based pharmaceutical industry’s self-regulation mechanisms and the commitment of IFPMA members to ethical promotion of medicines, to healthcare professionals, for the safety and benefit of patients worldwide.
It should be noted that the intention of the chart is not to provide a comprehensive analysis of regional and national association Marketing Codes or the IFPMA position. In addition, it does not include a precise account of national Codes’ requirements, depth of coverage or additional provisions.
For detailed information regarding provisions in a specific country, please refer to the respective national Code of Marketing Practices.